Related references
Note: Only part of the references are listed.Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome
Iusta Caminha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
FAS-L, IL-10, and double-negative CD4- CD8- TCR α/β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
Aude Magerus-Chatinet et al.
BLOOD (2009)
Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
Lorraine A. O' Reilly et al.
NATURE (2009)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
V. Koneti Rao et al.
PEDIATRIC BLOOD & CANCER (2009)
Multistep pathogenesis of autoimmune disease
Christopher C. Goodnow
CELL (2007)
NRAS mutation causes a human autoimmune lymphoproliferative syndrome
Joao B. Oliveira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Standard mutation nomenclature in molecular diagnostics - Practical and educational challenges
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
SNPs3D: Candidate gene and SNP selection for association studies
P Yue et al.
BMC BIOINFORMATICS (2006)
Single nucleotide polymorphisms in the apoptosis receptor gene TNFRSF6
JE Niemela et al.
MOLECULAR AND CELLULAR PROBES (2006)
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)
MM Vacek et al.
CLINICAL IMMUNOLOGY (2006)
Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95ΔTM), is the basis for ALPS Ia in a family with duplicated 3′ splice site AG in CD95 intron 5 on one allele
J Roesler et al.
BLOOD (2005)
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome
I Maric et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
E Holzelova et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
ConSeq: the identification of functionally and structurally important residues in protein sequences
C Berezin et al.
BIOINFORMATICS (2004)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Human non-synonymous SNPs: server and survey
V Ramensky et al.
NUCLEIC ACIDS RESEARCH (2002)
Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay
S Danckwardt et al.
BLOOD (2002)
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome
JJH Bleesing et al.
BLOOD (2001)
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
SE Straus et al.
BLOOD (2001)
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression
U Lopatin et al.
BLOOD (2001)
Autoimmune Lymphoproliferative Syndrome type III, an indefinite disorder
JV Ten Bosch et al.
LEUKEMIA & LYMPHOMA (2001)
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
RM Siegel et al.
SCIENCE (2000)
Share Paper
